Companies: 10,795·Total market cap: $144.5T
Biocartis Group N.V.

Biocartis Group N.V.

BIOGFOTCHealthcare
$0.66
$-3.84(-85.33%)
Market Cap$65406204
P/E Ratio
52W High$0.66
52W Low$0.66

Biocartis Group N.V. (BIOGF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

biogf · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Biocartis Group N.V. (BIOGF) measures how much investors pay for each dollar of the company's trailing earnings. BIOGF's current PE ratio of N/A is calculated by dividing its stock price of $0.66 by its TTM earnings per share of -$1.08.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
FY2025 est. EPS $-0.04
Based on 1 analyst
EPS (TTM)
-$1.08
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Biocartis Group N.V. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2019 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Biocartis Group N.V.
Biocartis Group N.V.You
BIOGF
$65MN/A-$1.08
Elegance Optical International Holdings Limited
Elegance Optical International Holdings Limited
EEOIF
$63MN/A
Goodness Growth Holdings, Inc.
Goodness Growth Holdings, Inc.
GDNSF
$61MN/A-$0.00
Herantis Pharma Oyj
Herantis Pharma Oyj
HRPMF
$59MN/A-$0.24
Karolinska Development AB (publ)
Karolinska Development AB (publ)
KDEVF
$69M129.97x$0.02
Kiaro Holdings Corp.
Kiaro Holdings Corp.
KIARF
$0MN/A-$0.42
MCI Onehealth Technologies Inc.
MCI Onehealth Technologies Inc.
MCIOF
$54MN/A

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-1.08
2021-12-31
FY2021
$-1.24
2020-12-31
FY2020
$-1.11
2019-12-31
FY2019
$-1.14

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Biocartis Group N.V. (BIOGF) measures how much investors pay for each dollar of the company's trailing earnings. BIOGF's current PE ratio of N/A is calculated by dividing its stock price of $0.66 by its TTM earnings per share of -$1.08.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.66 ÷ -$1.08 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

BIOGF pe ratio · 6 questions

BIOGF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.66 and TTM EPS of -$1.08. Data sourced from Financial Modeling Prep via BIOGF's SEC 10-K and 10-Q filings.

BIOGF PE ratioWhat is BIOGF PE ratioCurrent PE ratio of BIOGFBIOGF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Biocartis Group N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09